Most sold healthcare stocks in Q3 2022

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2022, measured as net reductions in reported share positions from Q2 2022 into Q3 2022. Notable reductions at the top of this list include BAUSCH HEALTH COS INC (BHC), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), PRECIGEN INC (PGEN). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
BHCBAUSCH HEALTH COS INC-15,890,036-$195.57K00133
BSXBOSTON SCIENTIFIC CORP-14,190,363$108.42K21316
CNCCENTENE CORP-6,683,105$4.33M12115
PGENPRECIGEN INC-6,255,998-$7.73K00111
ALHCALIGNMENT HEALTHCARE INC-5,326,239-$60.14K01102
CITHE CIGNA GROUP-4,562,438$2.08M02508
EVHEVOLENT HEALTH INC - A-3,912,829-$108.46K00101
GILDGILEAD SCIENCES INC-3,839,207-$2.43M075012
NVSNOVARTIS AG-SPONSORED ADR-3,395,058-$692.10K00516
ISRGINTUITIVE SURGICAL INC-3,388,293-$1.62M15309
BMYBRISTOL-MYERS SQUIBB CO-3,335,286-$70.70M0510218
MRKMERCK & CO. INC.-3,177,764-$105.92M0610022
CLDXCELLDEX THERAPEUTICS INC-2,311,966-$61.73K10012
NVONOVO-NORDISK A/S-SPONS ADR-2,221,086-$735.31K01205
BLUEBLUEBIRD BIO INC-2,052,890-$6.84K00101
ZNTLZENTALIS PHARMACEUTICALS INC-2,026,656-$56.95K00010
ME23ANDME HOLDING CO -CLASS A-1,816,300-$4.03K10103
EXELEXELIXIS INC-1,753,093-$119.00K00102
DOCSDOXIMITY INC-CLASS A-1,744,798-$66.03K01204
PRCTPROCEPT BIOROBOTICS CORP-1,543,788-$25610011
ZOMZOMEDICA CORP-1,507,000-$34100111
AMLXAMYLYX PHARMACEUTICALS INC-1,400,000$24.34K00101
SNYSANOFI-ADR-1,348,546-$1.08M02406
OPKOPKO HEALTH INC-1,158,915-$4.78K01112
NUVLNUVALENT INC-A-1,110,170-$15.05K00010
CGEMCULLINAN THERAPEUTICS INC-1,097,319-$14.07K01103
ABCLABCELLERA BIOLOGICS INC-1,055,500-$13.51K00101
GDRXGOODRX HOLDINGS INC-CLASS A-1,020,596-$20.19K01203
TGTXTG THERAPEUTICS INC-998,055$66.66K01103
DHRDANAHER CORP-994,721-$18.80M053114
ABBVABBVIE INC-980,914-$22.22M094017
ZTSZOETIS INC-947,797-$34.97M029212
CAHCARDINAL HEALTH INC-941,936$3.26M02417
DXCMDEXCOM INC-928,121-$1.85M01304
MRNAMODERNA INC-925,920-$7.48M13308
MGNXMACROGENICS INC-921,700-$2.46K00101
ATOSATOSSA THERAPEUTICS INC-894,285-$1.26K00101
AMGNAMGEN INC-812,584-$148.43K056012
ZLABZAI LAB LTD-ADR-798,748-$682.21K00303
BKDBROOKDALE SENIOR LIVING INC-784,116-$5.64K01102
INCYINCYTE CORP-754,216-$12.28K01315
IONSIONIS PHARMACEUTICALS INC-749,920-$217.18K02406
AAGILENT TECHNOLOGIES INC-733,575-$1.65M02316
SPROSPERO THERAPEUTICS INC-724,317-$26700101
CORTCORCEPT THERAPEUTICS INC-636,400-$1.75K00101
QSIQUANTUM-SI INC-631,294-$19.32K00102
OCGNOCUGEN INC-621,998-$2.06K00111
BIIBBIOGEN INC-602,077$10.42M01509
PHGKONINKLIJKE PHILIPS NVR- NY-598,668-$21.27K01102
OSURORASURE TECHNOLOGIES INC-592,476$35600101
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−17.5M−13.1M−8.7M−4.4M0.00Net change in reported shares (all institutional filers)BHCBSXCNCPGENALHCCIEVHGILDNVSISRGBMYMRKCLDXNVOBLUEZNTLMEEXELDOCSPRCTSymbol

Frequently asked questions about Most sold healthcare stocks in Q3 2022

  • What are the most sold Healthcare stocks in Q3 2022?

    The most sold healthcare stocks in Q3 2022 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2022, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2022?

    Among filers in this sector, net reductions were largest in companies such as BAUSCH HEALTH COS INC (BHC), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2022).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.